1) conduct post-authorisation safety studies in the presence of risks related to vaccines or other medical immunobiological preparations registered for emergency medical use. If doubts about these risks relate to more than one vaccine or other medical immunobiological preparations, the central executive authority in charge of shaping and implementing the state policy in the field of healthcare fosters the registration certificate holders to participate in the joint post-authorisation safety studies;